HROW News & Events

Sharp gains in Energy and Basic Materials helped power S&P 500 to fresh record highs to start the week, despite the continued uncertainty in the Middle East over the weekend, whereby President Trump has flatly rejected the latest proposals from Iran. ExxonMobilwas up by nearly 4% as WTI crude oil remained supported by the Straight of Hormuz shipping passage uncertainty, briefly topping the $100 per barrel mark.  Precious Metals group was also very strong, with Silver prices rising for the fifth straight session toward $88 per ounce and Gold topping $4,750 per ounce - Newmont Miningtopped $120 per share in regular trading and extended its gains above $121 afterhours - the highest level in about a month.  Communication Services sector buckled as shares of Alphabetfell 3%, though Semiconductors and Memory names remained strong - Nvidiatested record highs above $220 and Micronadded 7% to its meteoric 2026 rise, with a stock now up nearly 180% for the year.In the evening hours, S&P, e-minis and NASDAQ 100 contracts are both up 0.1%.  The earnings season has fizzled to a trickle though traders will still tune in to high-profile results out of Applied Materialsand Ciscolater in the week.Check out this evening's top movers from around Wall Street, compiled by The Fly.HIGHER AFTER EARNINGS -Quantum Computingup 14.7%Harmonicup 13.6%SI-BONEup 11.9%GoProup 9.9%PACS Groupup 9.9%Super Groupup 5.8%DOWN AFTER EARNINGS -ZoomInfodown 28.5%Hims & Hersdown 12.2%Harrowdown 12.2%WEBTOON Entertainmentdown 12.1%AST SpaceMobiledown 11.3%Bakktdown 10.8%CleanSparkdown 10.5%Ramaco Resourcesdown 7.7%LENZ Therapeuticsdown 5.0%Rigetti Computingdown 1.3%ALSO LOWER -GitLabdown 8.0% after announcing reduction in force

Reports Q1 revenue $44.2M vs. $47.83M last year. "The demand for Harrow's key products has never been stronger, and our visibility into our demand trajectory - across our portfolio - keeps us entirely on track to reach our forecasted financial goals for the year," said Mark L. Baum, Chief Executive Officer of Harrow. "Although our first-quarter reported revenue reflects an estimated $8 million gross-to-net reduction associated with our new commercial coverage for VEVYE, this adjustment does not reflect the profitable, recurring, and significant patient base established during the quarter. Harrow is now positioned to realize the full financial benefits of this coverage relationship beginning in Q2 2026."

Harrow announced that Iopidine 1% has been assigned a permanent J-Code by the Centers for Medicare & Medicaid Services, CMS. Effective July 1, 2026, Iopidine 1% will be reimbursed when administered in the in-office setting. J-Codes are CMS billing designations that allow physicians to be reimbursed directly for drugs administered in their offices. The assignment of a permanent J-Code removes a longstanding practical barrier to routine use of Iopidine 1% for office-based procedures, making it administratively and economically feasible for physicians to incorporate Iopidine 1% into standard glaucoma and ophthalmic laser procedure workflows.

LogiCare3PL announced it has been selected by Harrow as a distribution partner for Harrow's portfolio of ophthalmic disease management solutions. Effective February 1, 2026, LogiCare3PL is providing both non-title and 3PL title distribution services, supporting distribution of Harrow's products across the U.S. market. The agreement, effective February 1, 2026, covers LogiCare3PL's full suite of 3PL services, including non-title logistics support and title distribution for Harrow's products. Both organizations anticipate continued collaboration as Harrow expands its product offerings.